JP2024525693A5 - - Google Patents
Info
- Publication number
- JP2024525693A5 JP2024525693A5 JP2024501540A JP2024501540A JP2024525693A5 JP 2024525693 A5 JP2024525693 A5 JP 2024525693A5 JP 2024501540 A JP2024501540 A JP 2024501540A JP 2024501540 A JP2024501540 A JP 2024501540A JP 2024525693 A5 JP2024525693 A5 JP 2024525693A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- alkyl
- tautomer
- prodrug
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163222380P | 2021-07-15 | 2021-07-15 | |
| US63/222,380 | 2021-07-15 | ||
| PCT/US2022/037387 WO2023288109A1 (en) | 2021-07-15 | 2022-07-15 | N-heterocyclyl substituted 2-cyano-3-(naphthalen-2-yl)acrylamide derivatives as fluorophors for detection of amyloid and amyloid-like proteins for diagnosis of neurodegenerative disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525693A JP2024525693A (ja) | 2024-07-12 |
| JP2024525693A5 true JP2024525693A5 (cg-RX-API-DMAC7.html) | 2025-07-16 |
Family
ID=82943006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501540A Pending JP2024525693A (ja) | 2021-07-15 | 2022-07-15 | 神経変性障害の診断のためにアミロイドおよびアミロイド様タンパク質を検出するためのフルオロフォアとしてのn-ヘテロシクリル置換2-シアノ-3-(ナフタレン-2-イル)アクリルアミド誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240325572A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4370510A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024525693A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117916225A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022310502A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226490A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023288109A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019279001B2 (en) | 2018-05-31 | 2025-11-27 | Amydis, Inc. | Compositions and methods for detection of traumatic brain injury |
| US20240165274A1 (en) * | 2021-03-12 | 2024-05-23 | Amydis, Inc. | Methods of detecting systemic amyloidosis via binding to misfolded or aggregated protein |
| US20260217667A1 (en) * | 2023-01-18 | 2026-07-30 | Amydis, Inc. | Amyloid targeting agents |
| CN116178303B (zh) * | 2023-03-17 | 2024-04-02 | 许昌学院 | 一类含氮荧光染料、其合成方法及应用 |
| CN122208580A (zh) * | 2026-05-20 | 2026-06-16 | 上海健康医学院 | 一种全脑多脑区异常蛋白聚集的动物模型的构建方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106573880B (zh) * | 2014-03-19 | 2019-07-30 | 阿米达斯公司 | 淀粉样蛋白靶向剂及其使用方法 |
| EP3191107A2 (en) * | 2014-09-12 | 2017-07-19 | Amydis Diagnostics, Inc. | In vitro compositions comprising human sample and amyloid targeting agent |
| AU2019279001B2 (en) * | 2018-05-31 | 2025-11-27 | Amydis, Inc. | Compositions and methods for detection of traumatic brain injury |
| AU2019372432B2 (en) | 2018-11-02 | 2025-05-29 | Amydis, Inc. | Phosphate compounds for detecting neurological disorders |
| JP7591040B2 (ja) * | 2019-09-18 | 2024-11-27 | アミディス, インコーポレイテッド | リン酸化タウタンパク質への結合を介した神経障害を検出する方法 |
-
2022
- 2022-07-15 US US18/579,251 patent/US20240325572A1/en active Pending
- 2022-07-15 AU AU2022310502A patent/AU2022310502A1/en active Pending
- 2022-07-15 EP EP22757396.1A patent/EP4370510A1/en active Pending
- 2022-07-15 WO PCT/US2022/037387 patent/WO2023288109A1/en not_active Ceased
- 2022-07-15 CN CN202280060212.1A patent/CN117916225A/zh active Pending
- 2022-07-15 CA CA3226490A patent/CA3226490A1/en active Pending
- 2022-07-15 JP JP2024501540A patent/JP2024525693A/ja active Pending